Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Bon Natural Life ( (BON) ) has provided an announcement.
On September 1, 2025, Bon Natural Life Limited’s subsidiary, Xi’an App-Chem Bio (Tech) Co., Ltd, entered into a Sales Cooperation Agreement with Beijing Huahai Keyuan Technology Co., Ltd. This agreement allows Huahai Keyuan to market and sell Bon’s second-generation Apple Series products in China, aiming for sales of at least $18 million over two years. The products, which combine apple polyphenols with plant proteins, are designed to enhance weight management and metabolic health. This strategic partnership is expected to strengthen Bon’s market position in the nutraceutical sector, leveraging advanced extraction technology to deliver higher bioactivity and meet growing consumer demand for scientifically validated health solutions.
The most recent analyst rating on (BON) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Bon Natural Life stock, see the BON Stock Forecast page.
Spark’s Take on BON Stock
According to Spark, TipRanks’ AI Analyst, BON is a Neutral.
Bon Natural Life’s overall stock score is primarily impacted by its challenging financial performance and bearish technical indicators. While the stock appears undervalued based on its P/E ratio, operational and liquidity issues, along with negative market momentum, weigh heavily on its attractiveness.
To see Spark’s full report on BON stock, click here.
More about Bon Natural Life
Bon Natural Life Limited (BON) is a Cayman Islands company operating in the natural, health, and personal care industries. It is a leading bio-ingredient solution provider, specializing in the development of innovative health products, such as those incorporating apple polyphenols, to address market needs in weight management and metabolic health.
Average Trading Volume: 539,632
Technical Sentiment Signal: Sell
Current Market Cap: $10.62M
See more insights into BON stock on TipRanks’ Stock Analysis page.